Omicron News and Research

RSS

Despite losing federal money, California is still testing uninsured residents for covid — for now

California is still offering free covid testing to uninsured residents even though the federal government ran out of money to pay for it.

25 Apr 2022

Vaccine effectiveness against COVID-19 infection and related hospitalization

Researchers assessed the effectiveness of COVID-19 vaccines against COVID-19 infections and related hospitalizations.

25 Apr 2022

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The researchers aimed to estimate how effective vaccination was against severe COVID-19, caused by Omicron and Delta variants of the virus, in England.

25 Apr 2022

The challenges of Omicron

A new review published in sums up the position of Omicron as a potential threat to human health, especially in the context of controlling this pandemic.

25 Apr 2022

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

A recent review paper, published in the MDPI’s specialized journal COVID, highlights key features of the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – and examines the potential and roadblocks in using renewable marine resources in the fight against the coronavirus disease 2019 (COVID-19).

24 Apr 2022

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

Researchers estimate the effectiveness of primary vaccination and a booster dose in people with and without prior SARS-CoV-2 infection.

24 Apr 2022

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Anti-N antibodies may have lower sensitivity in mRNA-1273-vaccinated individuals who were previously infected with SARS-CoV-2.

24 Apr 2022

COVID-19 vaccine protection against omicron wanes over time, study shows

A study released April 22 in The Lancet Respiratory Medicine shows that a booster dose of the Pfizer COVID-19 vaccine provides strong protection, roughly 80% to 90%, in the first few months against hospital admissions and emergency department visits caused by the delta and omicron variants. However, against omicron, this protection wanes over time - even after a third dose.

23 Apr 2022

Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

Scientists have demonstrated the incidence of SARS-CoV-2 infection in cancer patients residing in Austria and Italy.

22 Apr 2022

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Researchers compared the vaccine effectiveness against infections by SARS-CoV-2 variant of concern Omicron BA.1 and BA.2 sublineages in Sweden.

22 Apr 2022

Continual genomic surveillance in Africa provides insights into evolving SARS-CoV-2 pandemic

Researchers described how SARS-CoV-2 genomic sequencing efforts in Africa helped identify two of the five SARS-CoV-2 VOCs, and their early analysis.

22 Apr 2022

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Researchers demonstrated SARS-CoV-2 evolution at the transcriptional level.

22 Apr 2022

Omicron News and Research

Despite losing federal money, California is still testing uninsured residents for covid — for now

Vaccine effectiveness against COVID-19 infection and related hospitalization

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The challenges of Omicron

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

COVID-19 vaccine protection against omicron wanes over time, study shows

Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Continual genomic surveillance in Africa provides insights into evolving SARS-CoV-2 pandemic

Study suggests SARS-CoV-2 is undergoing evolutionary changes at the functional RNA level in addition to the amino acid level

Antibody escape in SARS-CoV-2 Omicron spike protein

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Hybrid alphavirus-SARS-CoV-2 pseudovirus system rapidly measures neutralizing antibodies

CDC announces launch of the Center for Forecasting and Outbreak Analytics

Association between SARS-CoV-2 Omicron viral load and vaccination history

Evolution of SARS-CoV-2 variants

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News